Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 20, 2019 - Issue 2
Submit an article Journal homepage
695
Views
17
CrossRef citations to date
0
Altmetric
Review

Advances in orally administered pharmacotherapy for the treatment of migraine

Paolo MartellettiDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy;Regional Referral Headache Center, Sant’Andrea Hospital, Rome, ItalyCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-6556-4128View further author information
ORCID Icon &
Maria Adele GiamberardinoHeadache and Fibromyalgia Center, Geriatrics Clinic, Department of Medicine and Science of Aging and Ce.S.I.-Met, “G. D’Annunzio” University of Chieti, Chieti, ItalyORCID Iconhttp://orcid.org/0000-0002-3889-4551View further author information
ORCID Icon
Pages 209-218 | Received 13 Jun 2018, Accepted 13 Nov 2018, Published online: 26 Nov 2018

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Srinath Innani, Yashika Tomar, Vikas Rana & Gautam Singhvi. (2023) Navigating the landscape of psoriasis therapy: novel targeted pathways and emerging trends. Expert Opinion on Therapeutic Targets 0:0, pages 1-10.
Read now

Articles from other publishers (16)

Paolo Martelletti. 2022. Migraine in Medicine. Migraine in Medicine 639 881 .
Yi-Fan Li, Hui-Min Hu, Bo-Ning Wang, Yi Zhang, Xing Liu, Peng Mao & Bi-Fa Fan. (2021) Efficacy and Safety of Chuanxiong Qingnao Granule in Patients with Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-8.
Crossref
Fatima Tauqeer, Mollie Wood, Sarah Hjorth, Angela Lupattelli & Hedvig Nordeng. (2021) Perinatal use of triptans and other drugs for migraine—A nationwide drug utilization study. PLOS ONE 16:8, pages e0256214.
Crossref
Abimael González-Hernández, Bruno A. Marichal-Cancino, Enrique García-Boll & Carlos M. Villalón. (2020) The locus of Action of CGRPergic Monoclonal Antibodies Against Migraine: Peripheral Over Central Mechanisms. CNS & Neurological Disorders - Drug Targets 19:5, pages 344-359.
Crossref
Haibo Mei, Attila Márió Remete, Yupiao Zou, Hiroki Moriwaki, Santos Fustero, Lorand Kiss, Vadim A. Soloshonok & Jianlin Han. (2020) Fluorine-containing drugs approved by the FDA in 2019. Chinese Chemical Letters 31:9, pages 2401-2413.
Crossref
Eloísa Rubio-Beltran, Ka Yi Chan, AH Jan Danser, Antoinette MaassenVanDenBrink & Lars Edvinsson. (2019) Characterisation of the calcitonin gene-related peptide receptor antagonists ubrogepant and atogepant in human isolated coronary, cerebral and middle meningeal arteries. Cephalalgia 40:4, pages 357-366.
Crossref
Rosaria Greco, Chiara Demartini, Anna Maria Zanaboni, Elena Tumelero, Angelo Reggiani, Alessandra Misto, Daniele Piomelli & Cristina Tassorelli. (2020) FAAH inhibition as a preventive treatment for migraine: A pre-clinical study. Neurobiology of Disease 134, pages 104624.
Crossref
Damiana Scuteri, Annagrazia Adornetto, Laura Rombolà, MariaDiana Naturale, AdeleEmanuela De Francesco, Stefania Esposito, Mariacristina Zito, LuigiAntonio Morrone, Giacinto Bagetta, Paolo Tonin & MariaTiziana Corasaniti. (2020) Pattern of triptans use: a retrospective prescription study in Calabria, Italy. Neural Regeneration Research 15:7, pages 1340.
Crossref
Damiana Scuteri, Annagrazia Adornetto, Laura Rombolà, MariaDiana Naturale, AdeleEmanuela De Francesco, Stefania Esposito, Mariacristina Zito, LuigiAntonio Morrone, Giacinto Bagetta, Paolo Tonin & MariaTiziana Corasaniti. (2020) Pattern of triptans use: a retrospective prescription study in Calabria, Italy. Neural Regeneration Research 15:3, pages 1340.
Crossref
Carlo Piccinni, Sabina Cevoli, Giulia Ronconi, Letizia Dondi, Silvia Calabria, Antonella Pedrini, Immacolata Esposito, Valentina Favoni, Giulia Pierangeli, Pietro Cortelli & Nello Martini. (2019) A real-world study on unmet medical needs in triptan-treated migraine: prevalence, preventive therapies and triptan use modification from a large Italian population along two years. The Journal of Headache and Pain 20:1.
Crossref
Paolo Martelletti, Lars Edvinsson & Messoud Ashina. (2019) Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs). The Journal of Headache and Pain 20:1.
Crossref
Edita Navratilova, Jill Rau, Janice Oyarzo, Jason Tien, Kimberly Mackenzie, Jennifer Stratton, Bethany Remeniuk, Todd Schwedt, Trent Anderson, David Dodick & Frank Porreca. (2019) CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice. Cephalalgia 39:14, pages 1762-1775.
Crossref
Marina Borro, Martina Guglielmetti, Maurizio Simmaco, Paolo Martelletti & Giovanna Gentile. (2019) The future of pharmacogenetics in the treatment of migraine. Pharmacogenomics 20:16, pages 1159-1173.
Crossref
Robert Croop, Peter J Goadsby, David A Stock, Charles M Conway, Micaela Forshaw, Elyse G Stock, Vladimir Coric & Richard B Lipton. (2019) Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial. The Lancet 394:10200, pages 737-745.
Crossref
Giuseppe Tardiolo, Placido Bramanti & Emanuela Mazzon. (2019) Migraine: Experimental Models and Novel Therapeutic Approaches. International Journal of Molecular Sciences 20:12, pages 2932.
Crossref
Katharina Kamm, Andreas Straube & Lars Neeb. (2019) Migräne — Therapie im WandelMigraine — therapy in transition. MMW - Fortschritte der Medizin 161:12, pages 50-58.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.